2009
DOI: 10.1016/j.addr.2009.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Novel nanomedicine-based MRI contrast agents for gynecological malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
118
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 112 publications
(119 citation statements)
references
References 110 publications
0
118
0
1
Order By: Relevance
“…The endohedral fullerene's strong electronic properties can strongly enhance diagnostics. Such compounds are currently being investigated as a platform to detect cancer [63] , atherosclerosis [64] and arthritis [65] . Present day diagnostic limitations of both sensitivity and specificity have stalled progress on accurate, enhanced patient imaging.…”
Section: Fullerenes As Diagnosticsmentioning
confidence: 99%
“…The endohedral fullerene's strong electronic properties can strongly enhance diagnostics. Such compounds are currently being investigated as a platform to detect cancer [63] , atherosclerosis [64] and arthritis [65] . Present day diagnostic limitations of both sensitivity and specificity have stalled progress on accurate, enhanced patient imaging.…”
Section: Fullerenes As Diagnosticsmentioning
confidence: 99%
“…However, the direct use of magnetic nanoparticles as in vivo MRI contrast agent results in biofouling of the particles in blood plasma and formation of aggregates that are quickly sequestered by cells of the reticular endothelial system (RES) such as macrophages [16,17]. Furthermore, aggregated nanoparticles change their superparamagnetic response [7]. Therefore, in order to minimize biofouling and aggregation of particles and escape from the RES for longer circulation times, the nanoparticles are usually coated with a layer of hydrophilic and biocompatible polymer such as dextran [18], dendrimers [19], poly(ethylene glycol) (PEG) [20], and poly(vinyl pyrrolidone) (PVP) [21][22][23].…”
mentioning
confidence: 99%
“…Usually, accumulation of contrast agents is essential to achieve MR imaging (MRI) and high-resolution images. 7,8 Most of contrast agents for MRI are based on either iron oxide particle or gadolinium (III) (Gd(III))-chelated complexes. Gd(III)-based contrast agents have a low r 2 /r 1 ratio and are frequently used to generate positive contrast (increased signal intensity) in T 1 -weighted images.…”
Section: 6mentioning
confidence: 99%
“…Recently, various nanoscale carriers such as liposomes, micelles, and polymeric nanoparticles have been modified or incorporated with the MRI contrast agent Gd(III). 8,9 Liposomal nanocarriers are able to carry multiple reporter moieties such as peptides and antibodies for the efficient and selective delivery of contrast agents into the pathological sites.…”
Section: 6mentioning
confidence: 99%